Abortion, Missed
13
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
46%
6 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up
Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure
Vaginal Misoprostol In Management Of First Trimester Missed Abortion.
Amniotomy for Second-trimester Pregnancy Termination
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss
Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage
Research of Serum Procalcitonin, ESR, CRP And Leukocyte Levels in Fertile Missed Abortion Cases
Use of Fetoscopy in Missed Abortion
Cervical Rippening With Antiprogesterone in Midtrimester Abortions
Testing the Efficiency of Karman Curette in the Treatment of Misoprostol Failure in Women With Missed Abortion
Comparison of Single and Repeated Dose of Vaginal Misoprostol for the Treatment of Early Pregnancy Failure
Misopristol Versus Pitocin for Second Trimester Abortion